FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to the use of a clathrate complex of 9-phenyl-2,3,4,5,6,7,8,9-octahydro-1H-selenoxanthene with β-cyclodextrin for increasing or restoring libido and improving sexual function in androgen deficiency in males. The mass ratio of 9-phenyl-2,3,4,5,6,7,8,9-octahydto-1H-selenoxanthene and β-cyclodextrin is from 1:1 to 1:10.
EFFECT: invention allows for an increase or restoration of libido and improvement of sexual function in androgen deficiency in males due to an increase in a number of stem and semi-stem spermatogonia, increase in the pool of testosterone-synthesizing cells (Leydig cells), as well as Sertoli cells in testicles.
1 cl, 4 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR CORRECTION OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOTOXIC EFFECT | 2019 |
|
RU2782758C2 |
STIMULATOR OF REPARATIVE REGENERATION PROCESSES OF TESTICULAR TISSUE | 2019 |
|
RU2778238C2 |
USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR TREATMENT OF PATHOZOOSPERMIA | 2019 |
|
RU2782140C2 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
METHOD FOR STIMULATION OF SPERMATOGENESIS | 2016 |
|
RU2653779C1 |
METHOD OF CORRECTING, CAUSED BY CYTOSTATIC IMPACT | 2009 |
|
RU2406527C1 |
METHOD FOR STIMULATION OF SPERMATOGENESIS | 2016 |
|
RU2652902C1 |
REMEDY FOR DELAYED EFFECTS OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC EFFECT | 2019 |
|
RU2717240C1 |
METHOD OF STIMULATION OF IMPAIRED SPERMATOGENESIS AND SYNTHESIS OF TESTOSTERONE USING TRANSPLANTATION OF THE NEONATAL TESTICULAR TISSUE | 2017 |
|
RU2669027C1 |
Authors
Dates
2022-10-21—Published
2019-09-18—Filed